Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Management of women with multiple sclerosis through pregnancy and after childbirth.
Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
Novantrone
Glatiramer acetate induced hepatotoxicity.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Myelin in cartilaginous fish.
Neuro-Immune Interactions at Barrier Surfaces.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Clinically isolated syndromes.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.

Pages